Clearlake Capital and Charlesbank Capital-backed symplr, a firm that designs and develops software solutions, completed the acquisition of Midas, a developer of products that will be secure, able to track and dispose of powerful drugs, from Conduent, a business process services company, for $340m. "As part of our strategy to streamline our portfolio, we consider divestitures of select businesses in order to enhance shareholder and client value. We believe this is a mutually beneficial transaction and we are focused on providing a seamless transition for our clients. We are committed to delivering robust business process solutions to all industries, including the healthcare industry," Cliff Skelton, Conduent President and CEO.